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ABSTRACT: Resin-bound N–sulfanylethylanilide (SEAlide) peptide was found to function as a crypto-thioester peptide. Exposure 
of the peptide resin to an aqueous solution under neutral conditions in the presence of thiols affords thioesters without accompanying 
racemization of C-terminal amino acids. Furthermore, the resin-bound SEAlide peptides react with N-terminal cysteinyl peptides in 
the absence of phosphate salts to afford ligated products, whereas soluble SEAlide peptides do not. This unexpected difference in 
reactivity of the SEAlide peptides allows for a one-pot/three-fragment ligation using resin-bound and unbound peptides. 
N–Sulfanylethylanilide (SEAlide) peptide 1 as a 9-fluorenyl-
methyloxycarbonyl (Fmoc) chemistry compatible crypto-thioe-
ster was developed, and its utility in native chemical ligation 
(NCL)1 has been extensively examined by our group.2 In the 
early examination,2a N–S acyl-transfer-mediated conversion of 
the amide-type SEAlide peptide 1 to the corresponding thioe-
ster-type SEAlide 2 was found to be effected by acidic treat-
ment such as 4 M HCl in DMF (Fig. 1). This early finding was 
applied to the thiolytic release of an alkylthioester peptide from 
resin-bound SEAlide peptide, in which treatment with 4 M HCl 
in DMF, followed by thiolytic release using sodium sul-
fanylethanesulfonate under neutral conditions was used. How-
ever, racemization of C-terminal amino acids was accompanied 
by the acidic treatment involved in this protocol.  
Figure 1. Chemical behavior of SEAlide peptides. 
Close investigation into the utilization of SEAlide peptide in 
NCL disclosed that the amide-type SEAlide peptide can partic-
ipate in NCL to yield ligated NCL product 3 without racemiza-
tion in the presence of phosphate salts, but not in the absence of 
phosphate salts.2b-f  
Scheme 1. Synthesis of Resin-bound SEAlide Peptides 
Here, phosphate salts are likely to function as an acid–base 
catalyst for the N–S acyl transfer and allow the amide-type 
SEAlide to work as a thioester in NCL without pre-converting 
to the thioester. Having been inspired by the role of phosphate 
salts in NCL using SEAlide peptide, we reexamined the thio-
lytic release of peptide thioesters from resin-bound SEAlide 
peptides for the establishment of a facile preparation of the thi-
oesters from SEAlide peptides. 
Reexamination began with the preparation of resin-bound 
model SEAlide peptides 4 using standard Fmoc solid-phase 
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 peptide synthesis (SPPS) (Scheme 1). Aminomethyl ChemMa-
trix® resin3 as an aqueous-solution-swelled resin was used for 
a solid support. Internal standard amino acids (Gly or Phe) and 
Fmoc aminoacyl N–sulfanylethylaniline (SEA) likers4 5 were 
successively coupled on the amino group of the resin by the ac-
tion of N,N’–diisopropylcarbodiimide (DIPCDI) and 1-hy-
droxybenzotriazole (HOBt) and O–(7-azabenzotriazol-1-yl)–
N,N,N’,N’–tetramethyluroniumu hexafluorophosphate (HATU) 
and N,N’–diisopropylethylamine (DIEA), respectively, in DMF. 
Resulting resins were brought to the chain elongation step to 
give requisite resin-bound peptides 4. 





















































0.27 93:7 31 — 
aDetermined by quantitative spectrophotometric monitoring fol-
lowing piperidine deprotection of the internal standard-incorpo-
rated resin; bPeak ratio on HPLC analysis; cIsolated yield; dDe-
termined by amino acid analysis; e25 °C; fIn the presence of 3 M 
Gn·HCl 
 
Initially, resin 4a (X = Ala, initial content of NH2: NH2 0.43 
mmol/g) was treated with 3-mercaptopropionic acid5 (MPA, 
5% (v/v)) in the presence of 40 mM tris(2-carboxyethyl)phos-
phine (TCEP) and 50 mM sodium ascorbate6 in an 0.2 M phos-
phate buffer at 50 °C for 12 h under several pH conditions. Grat-
ifyingly, MPA-thioester peptide 6a was released from the resin 
in 45–55% isolated yields. The ratio of hydrolyzed peptide 7a 
to 6a decreased in proportion to decrease of pH and optimal pH 
for thiolytic release was fixed at 4.0 (Table 1, entries 1–3). Ef-
ficacy of the release depended on reaction temperature. Alt-
hough the release at 25 °C did not accompany the formation of 
7a, isolated yield remained low (3.5%) (Table 1, entries 3 and 
4). On the basis of our previous finding that SEAlide peptide in 
solution functions as a thioester in NCL only in the presence of 
phosphate salts, we speculated that the release efficacy should 
depend on the concentration of phosphate (Table 1, entries 3, 6 
and 7). However, unequivocal dependency was not observed at 
all. More surprisingly, a reaction in 0.1 M 3-[4-(2-hydroxy-
ethyl)piperazin-1-yl]propane-1-sulfonic acid (HEPPS) at pH 
4.0 at 50 °C proceeded efficiently to afford desired thioester 6a 
in 51% isolated yield (Table 1, entry 8). 
 
Figure 2. N–S Acyl transfer of SEAlide peptide in solution or on 
resin. 
Here, of note, is the fact that the resin-bound SEAlide peptide 
could behave in a fashion different to that of resin-unbound 
SEAlide peptide. We assume that the reason for the difference 
results from the “concentration effect,” as shown in Fig. 2. 
Compared with SEAlide peptide in solution (1 and 2), it seems 
the peptide on resin generally exists under highly concentrated 
conditions. Thiolytic release of thioester peptides from amide-
type SEAlide peptide on resin 8 initially requires the N–S acyl-
transfer-mediated conversion of 8 to the corresponding thioe-
ster-type SEAlide peptide on resin 9. Under diluted solution 
conditions in HEPPS buffer, unimolecular reverse reaction of 
the thioester-type SEAlide peptide 2 to the amide form 1 pref-
erentially occurs, thereby inhibiting the formation of thioester 
6. On the other hand, a pseudo bimolecular reaction between 
amide-type and thioester-type SEAlide peptides on resin (8 and 
9) potentially proceeds to give N,S-dipepeptidyl SEAlide pep-
tide on resin 10 under concentrated resin-bound conditions. The 
resulting dipeptidyl peptide 10 remains intact, and a reaction 
with thiol yields the desired thioester 6. Formation of the resin-
bound dipeptidyl SEAlide peptide 10 under concentrated con-
 ditions is provably indispensable for the thiolytic release of thi-
oester from the resin. This hypothesis was partly confirmed by 
the experimental results in an HEPPS buffer that the higher con-
tent resin (highly concentrated) more efficiently gave the de-
sired thioester than the lower content resin (Table 1, entries 8–
10) 
Next, applicability of the thiolytic release protocol to various 
C-terminal amino acids was confirmed (Table 2). Except for 
Asn and His, peptide thioesters were obtained in reasonable iso-
lated yields. Low yield of Asn peptide 6f is provably attributa-
ble to the facile imide cyclization of carbonyl activated Asn res-
idue. In terms of His, the reaction was stopped (1 h) before com-
pletion due to the suppression of racemization. Since intrinsi-
cally optically unstable Ser thioester peptide was obtained along 
with 3% epimerized peptide after 12 h reaction,7 we concluded 
that attempted thiolytic release protocol using resin-bound 
SEAlide peptide should be of use for preparation of the thioe-
sters. Therefore, we tried to synthesize 28-residue thioester cor-
responding to the C-terminal region of chemokine CXCL14. 
Table 2. Thiolytic Release of Various Thioester from SEAl-
ide Resins 







1 Ala (4a) 12 93:7 53 1.5 
2 Gly (4b) 6 91;9 57 — 
3 Lys (4c) 12 96:4 58 — 
4 Arg (4d) 12 95:5 63 — 
5 Ser (4e) 12 92:8 72 4.8 
6 Asn (4f) 12 89:11 33 — 
7 His (4g) 1 91:9 33 3.0 
8 Leu (4h) 24 96:4 43 — 
9 Phe (4i) 24 89:11 52 — 
10 Val (4j) 72 96:4 43 — 
art = reaction time; bPeak ratio on HPLC analysis; cIsolated 
yield  
During the course of our study on CXCL14,8 we have utilized 
NCL for preparation of various CXCL14 analogues. For the 
facile introduction of substitution into the N-terminal region, 
practical and maneuverable synthetic protocols for the N-termi-
nal fragment have been demanded. Standard Fmoc protocols on 
Fmoc-His(MBom)-SEA linker9 5g incorporated ChemMatrix® 
resin, followed by on-resin deprotection with TFA–thioanisole–
m-cresol–1,2-ethanedithiol (EDT)–H2O (80:5:5:5:5, (v/v)) af-
forded resin-bound CXCL14 (1-28) SEAlide peptide. Exposure 
of the resulting resin to 5% (v/v) MPA in 0.2 M phosphate 
buffer (pH4.0) in the presence of 40 mM TCEP and 50 mM so-
dium ascorbate at 50 °C for 1 h gave C-terminal His thioester 
peptide 11 in 17% isolated yield. Having requisite alkylthioster 
fragment 11 corresponding to CXCL14 (1-28), we next con-
ducted one-pot/sequential three-fragment ligation for prepara-
tion of CXCL14, as shown in Scheme 2.  
The first NCL of 11 with N-terminal cysteinyl SEAlide pep-
tide 12 in 6 M guanidine HCl–0.2 M HEPPS (pH 6.0) in the 
presence of 30 mM TCEP at 37 °C for 3 h yielded ligated SEAl-
ide peptide 13 without accompanying a cyclic peptide derived 
from an intramolecular NCL reaction of 12. The addition of C-
terminal fragment 14 in a 1 M phosphate buffer into the reaction 
mixture then triggered the second NCL step to allow for the for-
mation of fully ligated product 14 in a one-pot manner through 
the phosphate-induced NCL of the amide-type SEAlide unit. 
Resulting 14 was then brought to the oxidative folding step to 
produce desired CXCL14. One-pot/sequential protocol with the 
use of alkylthioester and cysteinyl SEAlide in solution with or 
without phosphate salts is undoubtedly powerful strategy for 
protein chemical synthesis; however, control of stoichiomeric 
amounts of employed fragments is sometimes required for the 
efficient purification of the desired product. From this point of 
view, direct application of resin-bound amide-type SEAlide 
peptide to NCL with cysteinyl SEAlide peptide was attempted. 
As previously mentioned, the resin-bound SEAlide shows sim-
ilar reactivity for the thiolytic release in both phosphate and 
HEPPS buffers. Therefore, we hypothesized that the amide-
type SEAlide peptide on resin could participate in NCL in an 
HEPPS buffer whereas the SEAlide peptide in solution could 
not function as a thioester in this buffer system. This hypothesis 
prompted us to attempt the alternative N–to–C-directed sequen-
tial three-fragment ligation using a resin-bound SEAlide pep-
tide (H-LYRANA-SEAlide-resin 15), a cysteinyl SEAlide pep-
tide (H-CLYRANA-SEAlide 16) and a cysteinyl peptide (H-
CFGRK-NH2 17) (Scheme 3). 




Scheme 3. Sequential NCL Using Resin-bound and Soluble 
SEAlide Peptides 
 
 The first NCL without phosphate salts was achieved between 
15 and 16 in 6 M guanidine HCl in 0.1 M HEPPS buffer (pH 
6.9) in the presence of 40 mM MPAA10 and 40 mM TCEP at 
37 °C for 12 h to afford ligated SEAlide peptide 18, as shown 
in Fig 3, a and b. Although not less than four equivalents of 15 
was required for complete consumption of 16; only the desired 
peptide 18 was observed as peptide material on HPLC analysis. 
Because excess released highly reactive MPAA ester as aryl thi-
oester should react with an SEA unit on the resin to regenerate 
the resin-bound SEAlide, filtering out the resin gave solution 
containing ligated 18. In the first step, it is worth noting that 
different chemical environment of the SEAlide unit in 15 and 
16 resulted in the success of the first chemoselective ligation 
NCL. That is, the resin-bound SEAlide unit of 15 can react with 
the cysteinyl unit in HEPPS buffer, but not the soluble SEAlide 
unit of 16. Next, addition of 17 in 0.5 M phosphate buffer (pH 
6.6) in the presence of 40 mM TCEP into the above HEPPS 
buffer solution of 18 allowed the soluble SEAlide unit of 18 to 
work as a thioester to give fully ligated peptide 19 in 40 % iso-
lated yield (over two steps) (Fig. 3, c). 
 
Figure 3. Progress of sequential ligation using resin-bound 
SEAlide peptide 15: (a) first NCL (t = 0 h); first NCL (t = 12 
h); (c) second NCL (t = 24 h). *non-peptide (derived from 
buffer); **released SEAlide unit. 
Recycling of the filtered-out resin was also examined. After 
completion of the NCL of the cysteinyl peptide 16 with 10 
equivalents of 15 (12 h), the peptide resin was filtered out and 
regenerated by treatment with 40 mM TCEP and 50 mM so-
dium ascorbate in 6 M Gn·HCl (pH 3.2) for 2 h at 37 °C. The 
resulting SEAlide peptide resin was subjected to a second round 
of NCL with 10 equivalents of 15, and the attempted reaction 
was continued for 42 h through to completion. The reason for 
decrease in reactivity of the resin-bound SEAlide peptide re-
mained to be elucidated. Possible examinations could include 
the consumption of a hot reaction spot or insufficient regenera-
tion of the used resin. Further investigation into the decrease 
will be discussed in due course. 
Here, reactivity of the resin-bound SEAlide peptide in the 
formation of a thioester or NCL was elucidated. The SEAlide 
peptide in solution can participate in NCL only in the presence 
of phosphate salts, which is not the case for the resin-bound 
SEAlide peptide. Difference in chemical behavior of SEAlide 
peptide in solution versus on resin was successfully applied to 
one-pot/N–to–C-directed sequential ligation using different 
phase SEAlide peptides. 
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